Durch KI Einsatz in der Wirkstoffforschung und klinischen Studien,
Produktivität steigern, 'time to market' beschleunigen und Kosten senken.
September 01 - 03, 2025 | Palace Hotel Berlin, Germany
Referenten
Rafik Fellague-Chebra
Executive Global Group medical Director, Solid tumors franchise, GI cancers
Novartis
Executive Global Group medical Director, Solid tumors franchise, GI cancers
Novartis
Dimitri Metzger
Digital, Data & IT Business Partner for Generative AI, Medical & Development Uni
Merck
Digital, Data & IT Business Partner for Generative AI, Medical & Development Uni
Merck
Dr. Frank Richard
Vice President Medical, AI and Machine Learning, Oncology Drug Development
Heidelberg Pharma AG
Vice President Medical, AI and Machine Learning, Oncology Drug Development
Heidelberg Pharma AG
Klaus Suwelack
Digital Heaslth Expert
formerly The Janssen Pharmaceutical Companies of Johnson & Johnson
Digital Heaslth Expert
formerly The Janssen Pharmaceutical Companies of Johnson & Johnson
In Partnership With:
©2025 IQPC. All rights reserved.
Imprint:
Company information according to § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Address: Rosenstrasse 2, 10178 Berlin, Germany
Tel: 49 30 52 001 534
E-mail: info@iqpc.de
Registered at: Amtsgericht Charlottenburg, HRB 76720
VAT-Number: DE210454451
Management: Torben Haagh, Richard A. Worden, Michael R. Worden
Impressum:
Firmeninformationen entsprechend § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Adresse: Rosenstrasse 2, 10178 Berlin, Germany
Telefonnummer: 030 52001534
Email Adresse: info@iqpc.de
Registereintragungen: Amtsgericht Charlottenburg HRB 76720
Umsatzsteuer- Indentifikationsnummer DE210454451
Geschäftsführung: Torben Haagh, Richard A. Worden, Michael R. Worden
